Managing Intellectual Property Names Fox Attorneys as “IP Stars”

May 1, 2014 – Press Releases

Managing Intellectual Property has recommended Fox Rothschild’s intellectual property department in both New Jersey and Pennsylvania and named partners Gerard P. Norton, Ph.D., Richard C. Woodbridge, J. Mark Hand, Ph.D. and Marilou E. Watson as “IP Stars.”

In New Jersey, Fox was named for its 15-lawyer team based in the firm’s Princeton, Roseland and Atlantic City offices. The report highlighted Norton for his work in biotechnology, chemicals, medical devices and pharmaceuticals. Woodbridge was lauded for his work in communications, Internet domain names, electronics and software.

In Pennsylvania Fox was noted for the 20-lawyer team operating in throughout the Commonwealth. Hand was cited for his work counseling clients in the biotechnology and pharmaceutical industries. Watson was noted for her patent prosecution work in the pharmaceutical realm.

The IP Stars report highlights firms and individual attorney strengths in the intellectual property legal industry. The findings were based on more than 1,000 interviews and surveys with attorneys and clients.

Norton, former chair of the firm's Intellectual Property Department, current co-chair of the Pharmaceutical & Biotechnology Group and a member of the Steering Committee of Fox’s Life Sciences Practice Group, has extensive experience litigating complex matters pertaining to patents, trademarks, copyrights, trade secrets and breach of contract.

Woodbridge focuses his practice in mechanical and electrical inventions, with an emphasis on computers, computer software, technology transfer, licensing and the organization of high technology businesses. He has particular experience in all areas of intellectual property, including patents, trademark and copyrights, corporate and business startups, licensing, litigation, negotiations, computer law and communications law.

Hand has more than 20 years of experience in intellectual property law, with an emphasis on biotechnology and pharmaceutical matters including counseling clients regarding the validity and scope of intellectual property rights, complex due diligence reviews covering internal or licensing-in development and commercialization opportunities, freedom to operate analysis, and development of intellectual property portfolios.

Watson focuses her practice on all aspects of intellectual property law, with particular emphasis on foreign and domestic patent prosecution, client counseling, infringement analysis, patent invalidity and freedom to operate studies and Hatch-Waxman issues related to ANDA filings, licensing, due diligence, and divestiture matters in the chemical and pharmaceutical arts.